• Together with 34 European partners, DiCE participated in the preparation of the FOLIO (Sustainable FramewOrk for systematic quality of LIfe measurement and assessment for cancer patients and survivOrs) project […]

  • On June 30 at the DiCE General Assembly, Member Organisations will be asked to vote for their new Board Members. These are people Members would like to have represent them in making strategic decisions for DiCE. […]

  • Digestive Cancers Europe is so pleased to welcome another group of motivated and charming people to its fold – the team from OnkoAlianse! We would like to offer them a hearty reception – and allow them to […]

  • Digestive Cancers Europe (DiCE) and the International Liver Cancer Association (ILCA) Start Official Partnership

    DiCE and ILCA are both very pleased to report the signing of a Memorandum of Understanding between […]

  • Promising and heartening news for people undergoing treatment for pancreatic cancer in the Lombardy Region of Italy – our new Italian Member Codice Viola has successfully campaigned and added their expertise […]

  • Researchers have found a molecular signature of 27 microorganisms in stool samples that could predict whether patients are at high risk of pancreatic ductal adenocarcinoma (PDAC), the most common pancreatic […]

  • Digestive Cancers Europe launched its colorectal cancer (CRC) biomarkers project ‘Colorectal cancer: getting personal can be lifesaving’ in September of last year with the goal of producing educational mat […]

  • Zorana Maravic, CEO, Digestive Cancers Europe took part in the Global Colon Cancer Association’s Third Annual Virtual Global Colorectal Cancer Congress on March 31 – April 1, 2022. The theme of the event was “ […]

  • wrote a new post 2 years, 7 months ago

    We are very pleased to give a warm and hearty welcome to Codice Viola into our Digestive Cancers Europe network of Members. They are an Italian pancreatic cancer patient organisation working to improve the overall […]

  • wrote a new post 2 years, 7 months ago

    March 21 is Anal Cancer Awareness Day. Anal cancer is a rare cancer on the rise. In the EU 9.249 men and women were newly diagnosed with this cancer, in 2020.1

    The major risk factor for anal cancer is human […]

  • wrote a new post 2 years, 7 months ago

    March 22 is Lynch Syndrome Awareness Day. Lynch Syndrome is the most common inherited cancer syndrome in the world, with an estimation of 1 in 370 people carrying the genetic mutation.1 Lynch Syndrome is […]

  • wrote a new post 2 years, 7 months ago

    As a service to our Members Organisations, all materials that Digestive Cancers Europe produces are available to be translated and shared as widely as possible in local languages. To support this we are working on […]

  • The two most common types of oesophageal cancer are squamous cell carcinoma (OSCC) and adenocarcinoma (OAC). The majority of oesophageal cancers belong to the OSCC sub-type, accounting for more than 85% of all […]

  • Fuel for new and improved cancer screening programmes in Europe was released at the beginning of March in the form of two reports, one from the Science Advice for Policy by European Academies (SAPEA) and the […]

  • wrote a new post 2 years, 8 months ago

    In light of the current situation, Digestive Cancers Europe would like to highlight its concern at what is unfolding in the Ukraine and the human suffering that is being caused. We want to underline that we are […]

  • wrote a new post 2 years, 8 months ago

    Every year, 500.000 citizens in Europe are diagnosed with colorectal cancer, with 240.000 people a year sadly passing away from the disease. Patients who are diagnosed early (stage I), have a 90% chance of […]

  • wrote a new post 2 years, 8 months ago

    This article was kindly contributed by Katlijn Sanctorum (pictured below) of the Belgian Familial Adenomatous Polyposis Association (FAPA).

    Patients with hereditary tumor syndromes often receive a late […]

  • Load More

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.